DermTopic: Psoriasis

Filter Your Results

 

News

 

AXIM Biotech Begins Clinical Trials With Cannabigerol for P…

AXIM Biotechnologies, Inc. launched human dermatological clinical trials based on its proprietary, patent-pending topica…

The New Thinking on Psoriasis

A growing and convincing body of evidence links psoriasis to a host of emotional, psychiatric, and systemic comorbiditie…

Jerry Bagel, MD

Is Eli Lilly’s Taltz the Next Blockbuster Drug for Psorias…

Eli Lilly’s new psoriasis drug Taltz (ixekizumab) is set to generate sales in excess of $1 billion in the US and E…

Lilly’s Taltz Now Available for Psoriasis

Eli Lilly and Company's Taltz (ixekizumab) injection 80 mg/mL for the treatment of moderate-to-severe plaque psorias…

Global Derm Market Set to Soar Through 2022

The global dermatology market is set to boom from $20 billion in 2015 to $33.7 billion by 2022, representing a compound …

Thoughts on Superpotent Topical Corticosteroids in Children

"I think we've been overtrained that atrophy occurs all the time," says Neil J. Korman, MD. Caution is essential, but su…

Jerry Bagel MD, Neil J. Korman, MD

Largest Independent US Psoriasis Registry to Track Safety of…

The Corrona Psoriasis Registry will track the drug safety reporting for ixekizumab, Eli Lilly and Company's biologic…

Recent AAD Meeting Boasts Record Attendance

More than 18,500 people from 107 countries attended the American Academy of Dermatology’s 74th Annual Meeting held…

 
 

Contact Info

For advertising rates and opportunities:
Ali Kinnie
(917) 589-4160
akinnie@bmctoday.com

Rick Ehrlich
Associate Publisher
(609) 922-0337
rehrlich@bmctoday.com

About Practical Dermatology

Practical Dermatology is the monthly publication that provides coverage of medical care, cosmetic advancements, and practice management for clinicians in the field. With straight-forward, how-to advice from experts in various fields, we strive to enhance quality of care and improve the daily operation of dermatology practices.